PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry

A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

NCT00796367 ·Status: COMPLETED ·Phase: PHASE3

An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

NCT00109148 ·Status: COMPLETED ·Phase: PHASE2

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

NCT07310901 ·Status: RECRUITING ·Phase: PHASE1

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

NCT00533598 ·Status: COMPLETED ·Phase: PHASE2

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir

NCT05589688 ·Status: RECRUITING ·Phase: PHASE1

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

NCT06717425 ·Status: COMPLETED ·Phase: PHASE2

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

NCT04616339 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity

NCT06352437 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity

NCT07400679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

NCT00131430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Evaluation of the Implementation of Drug Prescription Recommendations Using Clinical Decision Support in Patients With Severe Obesity: Retrospective Study

NCT06517303 ·Status: ACTIVE_NOT_RECRUITING

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

NCT06867718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

NCT07232719 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

NCT07002905 ·Status: COMPLETED ·Phase: PHASE2

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

Obese Patients With or Without Comorbidities (RIO-North America)

NCT00029861 ·Status: COMPLETED ·Phase: PHASE3

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

NCT07594093 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Evaluating Weight Loss Outcomes in Patients With Overweight or Obesity

NCT07551193 ·Status: ACTIVE_NOT_RECRUITING

A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants

NCT06139055 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

NCT00483171 ·Status: TERMINATED ·Phase: PHASE3

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 ·Status: RECRUITING ·Phase: PHASE3